Arkolith/Insider Trading/IOBT/Form 4

Vivo Capital Fund IX, L.P.

10% OwnerIO Biotech, Inc. (IOBT) · full profile →Form 4 · filed Nov 12, 2021
Net Buying
Open-Market Buys
$9.1M
Open-Market Sells
$0
Net Open-Market Flow
$9.1M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 9, 2021Conversion(C)2.4M——2.4M
Nov 9, 2021Buy(P)650K$14.00$9.1M3.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 9, 2021Conversion(C)188K—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-037658) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML